Free shipping on all orders over $ 500

PTD-p65-P1 Peptide TFA

Cat. No. M55225

All AbMole products are for research use only, cannot be used for human consumption.

PTD-p65-P1 Peptide TFA Structure
Size Price Availability Quantity
5mg USD 300  USD300 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PTD-p65-P1 Peptide TFA is a potent, selective nuclear transcription factor NF-κB inhibitor and derives from the p65 subunit of NF-κB amino acid residues 271-282, which selectively inhibits NF-κB activation induced by various inflammatory stimulation, down-regulate NF-κB-mediated gene expression and up-regulate apoptosis. PTD-p65-P1 Peptide TFA (150 μM; 12-24 h) inhibits the SP-53 cells proliferation.

Sequence: DRQIKIWFQNRRMKWKKQLRRPSDRELSE

Chemical Information
Molecular Weight 3943.52
Formula C170H276F3N57O46S
Solubility (25°C) Water 100 mg/mL
Storage -20°C, protect from light, dry, sealed
Related NF-κB Products
DCZ5418 

DCZ5418 is an inhibitor of TRIP13.

Ro 106-9920 

Ro 106-9920 is a potent inhibitor of NF-kappaB.

MRS2693 trisodium 

MRS2693 trisodium is a selective P2Y6 agonist with an EC50 value of 0.015 μM.

Narlumosbart

Narlumosbart is a human IgG4ҡ monoclonal antibody (mAb) that targets Receptor Activating Factor for Nuclear Factor κB Ligand (RANKL) and can be used in studies related to Giant Cell Tumor of Bone (GCTB).

Ac2-26

Ac2-26, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury.

  Catalog
Abmole Inhibitor Catalog




Keywords: PTD-p65-P1 Peptide TFA supplier, NF-κB, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.